CIK 0001266806 · Non-accelerated filer<br>Smaller reporting company
Vivani Medical, Inc.
Sign in to watch- Ticker
- VANI
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 020692322
- Phone
- 415-506-8462
- Business address
- 1350 S. LOOP ROAD, ALAMEDA, CA, 94502
- Former names
- SECOND SIGHT MEDICAL PRODUCTS INC, SECOUND SIGHT MEDICAL PRODUCTS INC
- Open-market buys, last 90 days
- $19,645
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$19,645. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-12 | Dwyer Donald Chief Business Officer | Purchase | +5,000 | $0.83 | $4K | 60,000 |
| 2026-11-12 | Dwyer Donald Chief Business Officer | Purchase | +15,000 | $1.03 | $15K | 75,000 |
| 2026-10-15 | Mendelsohn Aaron Director | Gift | −20,000 | 168,170 | ||
| 2026-07-28 | Dwyer Donald Chief Business Officer | Grant or award · Common Stock Option | +70,000 | 70,000 | ||
| 2026-07-28 | Dwyer Donald Chief Business Officer | Grant or award · RSUs | +35,000 | 35,000 | ||
| 2026-07-28 | Porter Lisa Ellen Chief Medical Officer | Grant or award · Common Stock Option | +80,000 | 80,000 | ||
| 2026-07-28 | Porter Lisa Ellen Chief Medical Officer | Grant or award · RSUs | +40,000 | 40,000 | ||
| 2026-07-28 | Baldor Anthony Chief Financial Officer | Grant or award · Common Stock Option | +75,000 | 75,000 | ||
| 2026-07-28 | Baldor Anthony Chief Financial Officer | Grant or award · RSUs | +37,500 | 37,500 | ||
| 2026-07-28 | Le Truc Chief Operations Officer | Grant or award · Common Stock Option | +160,000 | 160,000 | ||
| 2026-07-28 | Le Truc Chief Operations Officer | Grant or award · RSUs | +80,000 | 80,000 | ||
| 2026-07-28 | Mendelsohn Adam Chief Executive Officer | Grant or award · Common Stock Option | +200,000 | 200,000 | ||
| 2026-07-28 | Mendelsohn Adam Chief Executive Officer | Grant or award · RSUs | +100,000 | 100,000 | ||
| 2026-07-27 | BRADBURY DANIEL Director | Grant or award · Non-Qualified Stock Option (right to buy) | +7,965 | $1.30 | $10K | 7,965 |
| 2026-07-15 | Williams Gregg Director | Purchase | +793,650 | $1.26 | $1000K | 36,912,736 |
| 2026-06-24 | Moretti August J Director | Grant or award · Non-Qualified Stock Option (right to buy) | +36,000 | $1.22 | $44K | 36,000 |
| 2026-06-24 | Williams Gregg Director | Grant or award · Non-Qualified Stock Option (right to buy) | +36,516 | $1.22 | $45K | 36,516 |
| 2026-06-24 | Popoff Alexandra L. Director | Grant or award · Non-Qualified Stock Option (right to buy) | +36,516 | $1.22 | $45K | 36,516 |
| 2026-06-24 | BRADBURY DANIEL Director | Grant or award · Non-Qualified Stock Option (right to buy) | +36,516 | $1.22 | $45K | 36,516 |
| 2026-06-24 | Mendelsohn Aaron Director | Grant or award · Non-Qualified Stock Option (right to buy) | +36,516 | $1.22 | $45K | 36,516 |
Page 1 of 20 · 397 trades